Biolinq Incorporated
Introducing Biolinq ShineTM
SAN DIEGO, United States · Founded 2015 · $158.0M raised
- Headquarters
- SAN DIEGO, California
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2C
- Website
- biolinq.com
- Total Funding
- $158.0M
- Last Round
- $100.0M Series CApr 2025
- Rounds
- 2
About
Biolinq develops biowearable biosensing platforms for metabolic health monitoring. Biolinq Shine is the first FDA-cleared needle-free continuous glucose sensor.
Summary
Biolinq Incorporated is a Biotech company based in SAN DIEGO, United States, founded in 2015. It has raised $158.0M in total across 2 rounds, most recently a $100.0M Series C round in Apr 2025. Investors include Alpha Wave Ventures.
Tech & App Stack
15 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...